Shay Capital LLC Inhibikase Therapeutics, Inc. Transaction History

Shay Capital LLC

  • $684 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.63 - $1.44 $5,853 - $13,380
-9,292 Reduced 46.46%
10,708 $8,000
Q3 2021

Nov 15, 2021
BUY
$1.79 - $2.81 $35,800 - $56,200
20,000 New
20,000 $38,000

Others Institutions Holding IKT

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Inhibikase Therapeutics, Inc.

IKT Quotes by TradingView
  • Ticker IKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,227,100
  • Market Cap $30.8M
  • Description
  • Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointes...
More about IKT
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email